4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-052337
Director bought 950,000 shares at $18.00 ($17,100,000)
- Director acquired 6,114,330 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Peter A. Director | 2020-09-25 | Purchase | +475,000 | $18.00 | $8,550,000 | 475,000 | I: show line 1 in the form |
| Thompson Peter A. Director | 2020-09-29 | Conversion | +4,025,076 | 4,500,076 | I: show line 2 in the form | ||
| Thompson Peter A. Director | 2020-09-29 | Conversion | +1,076,891 | 5,576,967 | I: show line 3 in the form | ||
| Thompson Peter A. Director | 2020-09-29 | Conversion | +518,191 | 6,095,158 | I: show line 4 in the form | ||
| Thompson Peter A. Director | 2020-09-29 | Conversion | +380,133 | 6,475,291 | I: show line 5 in the form | ||
| Thompson Peter A. Director | 2020-09-29 | Conversion | +114,039 | 114,039 | I: show line 6 in the form | ||
| Thompson Peter A. Director | 2020-09-25 | Purchase | +475,000 | $18.00 | $8,550,000 | 475,000 | I: show line 7 in the form |
| Open-market purchases · 950,000 sh · avg $18.00 · $17,100,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Thompson Peter A. Director | 2020-09-29 | Conversion · Series A Preferred Stock | −4,025,076 | 0 | I: show line 8 in the form | |||||
| Thompson Peter A. Director | 2020-09-29 | Conversion · Series B Preferred Stock | −1,076,891 | 0 | I: show line 9 in the form | |||||
| Thompson Peter A. Director | 2020-09-29 | Conversion · Series C Preferred Stock | −518,191 | 0 | I: show line 10 in the form | |||||
| Thompson Peter A. Director | 2020-09-29 | Conversion · Series D Preferred Stock | −380,133 | 0 | I: show line 11 in the form | |||||
| Thompson Peter A. Director | 2020-09-29 | Conversion · Series D Preferred Stock | −114,039 | 0 | I: show line 12 in the form |
Loading xslF345X03/doc4.xml…